In an interview with Moneycontrol, Gupta talked about the investment strategy of the newly launched Edelweiss Consumption ...

The Union Budget 2025, the second full budget of Modi 3.0 may bring a variety of changes such as income tax reforms, an ...

NDTV Profit tracks what analysts are saying about various stocks and sectors. Here are the analyst calls to keep an eye out ...

NATCO Pharma said that it has received approval of its ANDA for Everolimus tablets for oral suspension (TFOS), a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation.

CRO Brian Gleason shared Criteo's priorities for working with agencies to capitalize on curation and measurement opportunities in retail media and CTV.